Effect of the antitumor drug vinblastine on nuclear betaII-tubulin in cultured rat kidney mesangial cells

Invest New Drugs. 2003 Feb;21(1):15-20. doi: 10.1023/a:1022947706151.

Abstract

Tubulin, the main component of microtubules, is a major target for antitumor drugs such as vinblastine. We have recently discovered that the betaII isotype of tubulin is present in the nuclei of cultured rat kidney mesangial cells, smooth-muscle-like cells present in the renal glomerular mesangium (Walss C, Kreisberg JI, Ludueña RF: Cell Motil Cytoskeleton 42: 274-284, 1999). Here, we have investigated the effect of vinblastine on nuclear betaII-tubulin in these cells. We have found that, at concentrations of 15 nM and higher, vinblastine caused a reversible loss of betaII-tubulin from the nucleus. Our results raise the possibility that nuclear betaII-tubulin constitutes a population of tubulin that could be a novel target for antitumor drugs such as vinblastine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Cell Nucleus / drug effects*
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Glomerular Mesangium / cytology
  • Glomerular Mesangium / drug effects*
  • Glomerular Mesangium / metabolism
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Tubulin / metabolism*
  • Vinblastine / pharmacology*

Substances

  • Antineoplastic Agents, Phytogenic
  • Tubulin
  • Vinblastine